217 results
Page 9 of 11
8-K
EX-99
9gs5e36wul2e33vlj
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
424B5
vt9o9 trvz9
2 Feb 06
Prospectus supplement for primary offering
12:00am
S-3ASR
001d6ur cnvk
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
4tv5fj
30 Jan 06
Regulation FD Disclosure
12:00am
S-3ASR
EX-10.1
71wslmmv5xw75i9y
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
falumjx9t c0wc6
11 Jan 06
LABA Update Conference Call
12:00am
DEF 14A
giwtjc
12 May 05
Definitive proxy
12:00am
424B3
239z3
9 May 05
Prospectus supplement
12:00am
10-K
3nub702n
29 Mar 05
Annual report
12:00am
10-Q
EX-4.2
p4vsykzys2z
17 Nov 04
Quarterly report
12:00am